Genentech's new drug for an age-related disease that causes blindness has been linked to an elevated risk of stroke. The company's own large scale study of the eye drug, Lucentis, confirmed tentative findings from earlier clinical trials showing that the medication can increase the rate of strokes. Genentech has sent a letter alerting eye doctors to the risk of stroke from its macular degeneration treating drug. An interim analysis of a large 5,000 patient trial shows that 1.2% of patients given a 0.5 milligram dose of the drug suffered a stroke, compared with 0.3% of patients given a 0.3 milligram dose.
Stay Informed
Get the latest on class action lawsuits, settlements & more! Subscribe to our free weekly newsletter.
Get our Newsletter!
Submit a New Complaint
Been wronged by a similar product or service?
Click here to send us your complaint.
Reader Comments
Posted by
Pkg
on
Pkg
on
Since my last lucentis injection my life and health has been ruined
Posted by
New Jersey
on
New Jersey
on
Caused blindness and eye infection.
Posted by
Florida
on
Florida
on
My father was getting Lucentis injections in his eyes for approx. 2 months. 2 days after his last injection he suffered a stroke and passed away.
